FDA proposes new rule on direct to consumer ads

The FDA has proposed a new rule to amend its direct-to-consumer regulations covering broadcast ads and would require info about side effects and contraindications to be presented in a “clear, conspicuous and neutral manner.” Go here for the story. UPDATE 4/13: Mass Tort Defense blog has more on the story here.